The Quilter Academy recently marked the graduation of 124 newly qualified advisers at a ceremony in London. Among those celebrating a new chapter in their The Quilter Academy recently marked the ...
EMPAVELI®(pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in Canada ...
During pregnancy, the maternal immune system must engage in a fine balancing act: maintaining tolerance to the fetal ...
When Mundo Pol opened earlier this month inside the Warnors Center, it marked a turnaround for the nearly 100-year-old ...
NORTH FOND DU LAC, WI - April 02, 2026 - PRESSADVANTAGE - FZE Manufacturing has announced a significant expansion of ...
Tucking into roast lamb this Easter holliday with all the family? Christine Austin selects the best red wines you can buy off ...
Wipro’s strategic pivot with the AI-Native Business & Platforms Unit positions it for scalable growth, sharper competitiveness, and stronger Consulting-led, AI-driven client outcomes, building a solid ...
PPST Solution’s expanded portfolio includes EA Elektro-Automatik for high-power DC power test solutions, an ideal ...
The evaluation will compare AI-based predictions with actual rainfall and climate data, says IMD director general Mrutyunjay ...
C3 glomerulopathy (C3G) and immune complex membranoproliferative glomerulonephritis (IC-MPGN) are rare and progressive kidney diseases, caused by problems in the immune system. They are two distinct ...
Complement 3 glomerulopathy (C3G) is a rare kidney disease that is also considered an autoimmune disorder. There is no single cure for C3G, but several treatments may slow disease progression, protect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results